Analyst Downgrades – Cytori Therapeutics (NASDAQ:CYTX) Stock Gets Downgraded By B. Riley from Buy to Neutral

ME Staff
-
0

Analyst Ratings For Cytori Therapeutics (NASDAQ:CYTX)

Today, Cytori Therapeutics (NASDAQ:CYTX) stock was downgraded by B. Riley from Buy to Neutral.

There are 1 hold rating, 1 buy rating on the stock.

The current consensus rating on Cytori Therapeutics (NASDAQ:CYTX) is Buy (Score: 2.50) with a consensus target price of $6.15 per share, a potential 1,181.52% upside.

Some recent analyst ratings include

  • 7/25/2017-B. Riley was Downgraded by analysts at B. Riley from a “Buy ” rating to a ” Neutral” rating.
  • 6/28/2016-Roth Capital Reiterated Rating of Buy.

Recent Insider Trading Activity For Cytori Therapeutics (NASDAQ:CYTX)
Cytori Therapeutics (NASDAQ:CYTX) has insider ownership of 2.60% and institutional ownership of 8.65%.

  • On 8/10/2016 John David Harris, VP, bought 2,500 with an average share price of $2.03 per share and the total transaction amounting to $5,075.00. View SEC Filing
  • On 6/14/2016 Gail K Naughton, Director, bought 1,000 with an average share price of $2.10 per share and the total transaction amounting to $2,100.00. View SEC Filing
  • On 5/13/2016 John David Harris, VP, bought 2,000 with an average share price of $2.71 per share and the total transaction amounting to $5,420.00. View SEC Filing
  • On 3/9/2016 David Rickey, Director, bought 150,000 with an average share price of $0.19 per share and the total transaction amounting to $28,500.00. View SEC Filing
  • On 9/3/2015 Tommy G Thompson, Director, bought 25,449 with an average share price of $0.37 per share and the total transaction amounting to $9,416.13. View SEC Filing
  • On 9/2/2015 Jeremy B Hayden, VP, bought 8,200 with an average share price of $0.36 per share and the total transaction amounting to $2,952.00. View SEC Filing
  • On 8/28/2015 David Rickey, Director, bought 56,000 with an average share price of $0.31 per share and the total transaction amounting to $17,360.00. View SEC Filing

Recent Trading Activity for Cytori Therapeutics (NASDAQ:CYTX)
Shares of Cytori Therapeutics closed the previous trading session at 0.480 down -0.630 -56.77% with 7,464,054 shares trading hands.